LifeSci Synthorx Synthorx is a biotechnology company using synthetic biology to synthesize solutions. Synthorx in the NewsFrench Pharmaceutical giant, Sanofi, has announced that it will pay $2.5B to acquire Synthorx, a La Jolla based developer of a new class of cancer fighting drugs.December 9, 2019 Visit WebsiteShare this...FacebookTwitterLinkedinEmail OTHER COMPANIES Back to All Companies
French Pharmaceutical giant, Sanofi, has announced that it will pay $2.5B to acquire Synthorx, a La Jolla based developer of a new class of cancer fighting drugs.December 9, 2019